Kezar Life Sciences, Inc. (KZR) Stock Total Returns
Growth of $10,000 chart
2021-05-11 to 2026-05-11 to
$
%
%
Loading chart…
Investment Performance
Final Value
$1,444
Total Return
-85.56%
CAGR
-32.10%
Dividends
$0.00
Yield on Cost
0.00%
Rolling Returns
1-Month (21 Trading Days)
| Average | -0.55% |
| Median | -2.84% |
| Best | +122.71% |
| Worst | -66.01% |
| % of Windows Positive | 39.8% |
1-Year (252 Trading Days)
| Average | -36.61% |
| Median | -43.63% |
| Best | +103.92% |
| Worst | -90.59% |
| % of Windows Positive | 14.0% |
3-Year (756 Trading Days)
| Average | -91.22% |
| Median | -91.73% |
| Best | -68.42% |
| Worst | -97.63% |
| % of Windows Positive | 0.0% |
Risk Metrics
| Maximum Drawdown | -98.04% |
| Average Drawdown | -72.06% |
| Drawdown Duration | 1035 Trading Days (Unrecovered) |
| Sortino Ratio | -0.23 |
| Calmar Ratio | -0.33 |
| CVaR (5%) | -9.36% |
Yearly Returns
| Year | Percentage | Abs. Return | Dividends | Taxes | Trans. Costs |
|---|---|---|---|---|---|
| 2026 partial | +15.90% (+50.88% ann.) | +$1589.58 | $0.00 | $0.00 | $0.00 |
| 2025 | -6.40% | $639.74 | $0.00 | $0.00 | $0.00 |
| 2024 | -29.26% | $2926.33 | $0.00 | $0.00 | $0.00 |
| 2023 | -86.51% | $8650.57 | $0.00 | $0.00 | $0.00 |
| 2022 | -57.89% | $5789.47 | $0.00 | $0.00 | $0.00 |
| 2021 | +220.31% | +$22030.60 | $0.00 | $0.00 | $0.00 |
| 2020 | +30.18% | +$3017.51 | $0.00 | $0.00 | $0.00 |
| 2019 | -83.01% | $8300.85 | $0.00 | $0.00 | $0.00 |
| 2018 partial | +32.96% (+71.45% ann.) | +$3295.77 | $0.00 | $0.00 | $0.00 |
Market Regimes
about| Regime | Period | Percentage | Annual | Abs. Return | Dividends | Taxes | Trans. Costs |
|---|---|---|---|---|---|---|---|
| Secular stagnation / QE / low inflation / duration bull partial | June 21, 2018 – February 19, 2020 | -70.48% | -51.95% | $7047.89 | $0.00 | $0.00 | $0.00 |
| Pandemic shock / liquidity crash | February 20, 2020 – March 23, 2020 | -22.43% | -94.50% | $2243.47 | $0.00 | $0.00 | $0.00 |
| Policy bazooka / monetary euphoria | March 24, 2020 – November 6, 2020 | +8.51% | +14.04% | +$851.05 | $0.00 | $0.00 | $0.00 |
| Reopening reflation / fiscal boom / supply bottlenecks | November 9, 2020 – November 29, 2021 | +145.08% | +134.07% | +$14508.33 | $0.00 | $0.00 | $0.00 |
| Inflation shock / duration crash / aggressive tightening | November 30, 2021 – November 9, 2022 | -53.90% | -56.05% | $5389.61 | $0.00 | $0.00 | $0.00 |
| Disinflation rebound / AI-led narrow bull / higher-for-longer | November 10, 2022 – September 17, 2024 | -92.12% | -74.60% | $9211.61 | $0.00 | $0.00 | $0.00 |
| Disinflationary easing / resilient growth / AI capex under oil-shock test partial | September 18, 2024 – May 11, 2026 | +25.69% | +14.93% | +$2568.86 | $0.00 | $0.00 | $0.00 |
Dividend History
| Date | Per Share | Yield % |
|---|---|---|
| Total | 0 payments |
No dividends recorded.
All calculations use split-adjusted closing prices. Dividends are reinvested on the ex-dividend date at that day's closing price.
For each rolling window, returns are calculated at every possible starting point:
return = (value[i] ÷ value[i − windowSize] − 1) × 100
- Windows
- 1-month = 21 trading days, 1-year = 252 trading days, 3-year = 756 trading days.
- Statistics
- Average: arithmetic mean. Median: middle value when sorted. Best / Worst: max and min. % Positive: share of windows with return > 0.
The series is segmented by calendar year:
return = (endValue ÷ startValue − 1) × 100
startValue is the last value of the prior year (or the first value for the initial year). Partial first/last years are flagged. Dividends, taxes, and transaction costs are scaled proportionally to the initial investment.